CDEK
← All drugs Report issue

human urinary kallidinogenase

Biologicalexperimental

Clinical trial activity

9 trials · 9 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
1

Earliest trial started Jan 1, 2013 (NCT02259738)

Timeline

2010s

  1. Jan 1, 2013

    Earliest Phase 2 Sponsor(trial)

2020s

  1. Jan 1, 2023

    Earliest Phase 1 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • kallidinogenase
  • padutin
  • urinary kallidinogenase

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07283159Phase 2Feb 1, 2026People's Liberation Army of China
NCT06848894N/AFeb 28, 2025Capital Medical University
NCT06085378N/AJan 1, 2024Sun Yat-Sen University
NCT06132880N/ADec 14, 2023Peking University, Tsinghua University
NCT06137300N/ADec 1, 2023Jinlin University
NCT06380699Phase 1Mar 16, 2023Government of China, Nanjing University
NCT02806128N/ANov 1, 2016General Hospital of Shenyang Military Region, People's Liberation Army of China
NCT03431909Phase 4Jan 1, 2014Capital Medical University
NCT02259738Phase 2Jan 1, 2013Capital Medical University
Showing 9 of 9 trials
Page 1 / 1

Organizations

Research & Development (9)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Capital Medical UniversityAcademic/Hospital3332013
People's Liberation Army of ChinaGovernment2122016
General Hospital of Shenyang Military RegionAcademic/Hospital1112016
Government of ChinaGovernment1112023
Jinlin UniversityAcademic/Hospital1112023
Nanjing UniversityAcademic/Hospital1012023
Peking UniversityAcademic/Hospital1012023
Sun Yat-Sen UniversityAcademic/Hospital1112024
Tsinghua UniversityAcademic/Hospital1112023
9 organizations
Page 1 / 1